ATYR Q1 2024 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$93M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$235,000

Gross Profit

$235,000100.0% margin

Operating Income

-$17M-7079.1% margin

Net Income

-$15M-6591.9% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$740,000

Balance Sheet

Total Assets

$113M

Total Liabilities

$29M

Stockholders' Equity

$84M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$235,000	$0	—
Gross Profit	$235,000	-$755,000	+131.1%
Operating Income	-$17M	-$13M	-30.1%
Net Income	-$15M	-$12M	-29.6%